Talzenna
Product Images NDC 0069-1751

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Talzenna (NDC 0069-1751). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Talzenna 01)

Chemical structure of the active ingredient in Talzenna, showing a complex molecular structure with fluorine atoms and a sulfonic acid derivative, consistent with a targeted pharmaceutical compound.*

FDA Label Image

Figure 1 (Talzenna 02)

A Kaplan-Meier plot showing progression-free survival probability (%) over time (months) comparing Talzenna (solid line) and chemotherapy (dashed line). The chart illustrates higher survival probabilities for Talzenna throughout the study period, with patient counts at risk provided below the time axis for both groups.*

FDA Label Image

Talzenna 02a

A survival curve chart comparing overall survival probability (%) over time in months between patients treated with Talzenna and those receiving chemotherapy. The chart includes the number of patients at risk at various time points up to 60 months, with Talzenna represented by a solid line and chemotherapy by a dashed line.*

FDA Label Image

Logo (Talzenna 03)

FDA Label Image

Logo (Talzenna 04)

FDA Label Image

Principal Display Panel (0.25 mg Capsule Bottle Label)

Talzenna 0.25 mg capsules label by Pfizer Laboratories Div Pfizer Inc. The label shows the active ingredient talazoparib, with a package size of 30 capsules. It includes storage instructions and prompts to see accompanying prescribing information. The label is marked Rx only.*

FDA Label Image

Principal Display Panel (0.25 Capsule Bottle Carton)

Packaging label for Talzenna 0.25 mg capsules (talazoparib) by Pfizer Laboratories Div Pfizer Inc. The label shows a box design for a 30-capsule bottle, with the strength prominently displayed as 0.25 mg. The label includes storage instructions, dosage use instructions, and manufacturer details including 'Made in Germany' and distributed by Pfizer Labs, Division of Pfizer Inc, New York.*

FDA Label Image

Principal Display Panel (1 mg Capsule Bottle Label)

Label for Talzenna (talazoparib) capsules, 1 mg strength, manufactured by Pfizer Laboratories Div Pfizer Inc. The label indicates a quantity of 30 capsules, includes storage instructions at 20°C to 25°C, and notes it is Rx only. The label also shows the NDC 0069-1195-30 and a barcode.*

FDA Label Image

Principal Display Panel (1 mg Capsule Bottle Carton)

The packaging label for Talzenna (talazoparib) capsules, 1 mg strength, containing 30 capsules. The label shows the Pfizer logo and specifies that it is Rx only. Storage instructions and distributor details (Pfizer Labs, New York, NY) are visible. The product is made in Germany.*

FDA Label Image

Talzenna 09

This packaging label is for Talzenna (talazoparib) capsules 0.5 mg, manufactured by Pfizer Laboratories Div Pfizer Inc. The label includes storage instructions, dosage use notice, and indicates a package size of 30 capsules. It also displays the NDC number 0069-1501-30, barcode, and prescription-only status.*

FDA Label Image

Talzenna 10

Packaging label for Talzenna 0.5 mg capsules by Pfizer Laboratories Div Pfizer Inc. The label indicates the active ingredient talazoparib, with a package containing 30 capsules. It includes storage instructions, dosage and use notes, and states the product is made in Germany.*

FDA Label Image

Talzenna 11

Label for Talzenna (talazoparib) capsules 0.75 mg by Pfizer Laboratories Division Pfizer Inc. The label states storage instructions, dosage information, and quantity of 30 capsules. It includes barcode, lot, and expiration placeholders.*

FDA Label Image

Talzenna 12

Carton label for Talzenna capsules 0.75 mg (talazoparib), distributed by Pfizer Laboratories Division of Pfizer Inc. The label states 30 capsules per package and Rx only. Storage instructions and dosage cautions are included, along with barcodes and manufacturing details indicating it is made in Germany.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.